SCINAI IMMUNOTHERAPEUTICS LTD. Expense From Share-based Payment Transactions With Employees
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Expense From Share-based Payment Transactions With Employees of ILS 3.33 million for the 3-month period ending 2020-06-30, per its 6-K filed 2020-10-02.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2020-10-02
- SCINAI IMMUNOTHERAPEUTICS LTD. expense from share-based payment transactions with employees for the quarter ending 2020-06-30 was 3.33M ILS, a 18.20% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. expense from share-based payment transactions with employees for the quarter ending 2019-06-30 was 4.07M ILS.
| Period end | Expense From Share-based Payment Transactions With Employees 3 month | Expense From Share-based Payment Transactions With Employees 6 month |
|---|---|---|
| 2020-06-30 | 3.33M ILS 6-K · filed 2020-10-02 | 3.53M ILS 6-K · filed 2020-10-02 |
| 2019-06-30 | 4.07M ILS 6-K · filed 2020-10-02 | 4.12M ILS 6-K · filed 2020-10-02 |